Thymosin β4 attenuates microcirculatory and hemodynamic destabilization in sepsis

Bibliography

• Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008;36:296-327
   PubMed Web of Science ®Google Scholar
• Levy MM, Rhodes A, Phillips GS, et al. Surviving sepsis campaign: association between performance metrics and outcomes in a 7.5-Year study. Crit Care Med 2015;43(1):3-12
   PubMed Web of Science ®Google Scholar
• Safer D, Elzinga M, Nachmias VT. Thymosin beta 4 and Fx, an actin-sequestering peptide, are indistinguishable. J Biol Chem 1991;266:4029-32
   PubMed Web of Science ®Google Scholar
• Malinda KM, Sidhu GS, Mani H, et al. Thymosin beta4 accelerates wound healing. J Invest Dermatol 1999;113:364-8
   PubMed Web of Science ®Google Scholar
• Grant DS, Kinsella JL, Kibbey MC, et al. Matrigel induces thymosin beta 4 gene in differentiating endothelial cells. J Cell Sci 1995;108(Pt 12):3685-94
   PubMedGoogle Scholar
• Bock-Marquette I, Saxena A, White MD, et al. Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair. Nature 2004;432:466-72
   PubMed Web of Science ®Google Scholar
• Sosne G, Szliter EA, Barrett R, et al. Thymosin beta 4 promotes corneal wound healing and decreases inflammation in vivo following alkali injury. Exp Eye Res 2002;74:293-9
   PubMed Web of Science ®Google Scholar
• Badamchian M, Fagarasan MO, Danner RL, et al. Thymosin beta (4) reduces lethality and down-regulates inflammatory mediators in endotoxin-induced septic shock. Int Immunopharmacol 2003;3:1225-33
   PubMed Web of Science ®Google Scholar
• Hinkel R, Trenkwalder T, Petersen B, et al. MRTF-A controls vessel growth and maturation by increasing the expression of CCN1 and CCN2. Nat Commun 2014;5:3970
   PubMed Web of Science ®Google Scholar
• Park BS, Lee JO. Recognition of lipopolysaccharide pattern by TLR4 complexes. Exp Mol Med 2013;45:e66
   PubMed Web of Science ®Google Scholar
• Taveira da Silva AM, Kaulbach HC, Chuidian FS, et al. Brief report: shock and multiple-organ dysfunction after self-administration of Salmonella endotoxin. N Engl J Med 1993;328:1457-60
   PubMed Web of Science ®Google Scholar
• Doi K, Leelahavanichkul A, Yuen PS, et al. Animal models of sepsis and sepsis-induced kidney injury. J Clin Invest 2009;119:2868-78
   PubMed Web of Science ®Google Scholar
• Ziegler T, Horstkotte J, Schwab C, et al. Angiopoietin 2 mediates microvascular and hemodynamic alterations in sepsis. J Clin Invest 2013. [Epub ahead of print]
   Google Scholar
• Grieger JC, Choi VW, Samulski RJ. Production and characterization of adeno-associated viral vectors. Nat Protoc 2006;1:1412-28
   PubMed Web of Science ®Google Scholar
• Weber C, Springer TA. Neutrophil accumulation on activated, surface-adherent platelets in flow is mediated by interaction of Mac-1 with fibrinogen bound to alphaIIbbeta3 and stimulated by platelet-activating factor. J Clin Invest 1997;100:2085-93
   PubMed Web of Science ®Google Scholar
• Kupatt C, Wichels R, Horstkotte J, et al. Molecular mechanisms of platelet-mediated leukocyte recruitment during myocardial reperfusion. J Leukoc Biol 2002;72:455-61
   PubMed Web of Science ®Google Scholar
• Schulz C, Schafer A, Stolla M, et al. Chemokine fractalkine mediates leukocyte recruitment to inflammatory endothelial cells in flowing whole blood: a critical role for P-selectin expressed on activated platelets. Circulation 2007;116:764-73
   PubMed Web of Science ®Google Scholar
• Hinkel R, El-Aouni C, Olson T, et al. Thymosin beta4 is an essential paracrine factor of embryonic endothelial progenitor cell-mediated cardioprotection. Circulation 2008;117:2232-40
   PubMed Web of Science ®Google Scholar
• Rossdeutsch A, Smart N, Dube KN, et al. Essential role for thymosin beta4 in regulating vascular smooth muscle cell development and vessel wall stability. Circ Res 2012;111:e89-102
   PubMed Web of Science ®Google Scholar
• Witzenbichler B, Westermann D, Knueppel S, et al. Protective role of angiopoietin-1 in endotoxic shock. Circulation 2005;111:97-105
   PubMed Web of Science ®Google Scholar
• David S, Park JK, Meurs M, et al. Acute administration of recombinant Angiopoietin-1 ameliorates multiple-organ dysfunction syndrome and improves survival in murine sepsis. Cytokine 2011;55:251-9
   PubMed Web of Science ®Google Scholar
• Kupatt C, Hinkel R, Pfosser A, et al. Cotransfection of vascular endothelial growth factor-A and platelet-derived growth factor-B via recombinant adeno-associated virus resolves chronic ischemic malperfusion role of vessel maturation. J Am Coll Cardiol 2010;56:414-22
   PubMed Web of Science ®Google Scholar
• Merx MW, Weber C. Sepsis and the heart. Circulation 2007;116:793-802
   PubMed Web of Science ®Google Scholar
• Hoesel LM, Niederbichler AD, Ward PA. Complement-related molecular events in sepsis leading to heart failure. Mol Immunol 2007;44:95-102
   PubMed Web of Science ®Google Scholar
• Ichinose F, Buys ES, Neilan TG, et al. Cardiomyocyte-specific overexpression of nitric oxide synthase 3 prevents myocardial dysfunction in murine models of septic shock. Circ Res 2007;100:130-9
   PubMed Web of Science ®Google Scholar